See also this year's filing and all EDGAR filings for this company.
PDF Report 0001328143_2021_Adamas_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001328143')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001328143, Adamas Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 111,736,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,598,000 |
| 3 | remainder_Assets | 6,695,000 |
| 4 | LiabilitiesCurrent | 34,867,000 |
| 5 | LiabilitiesNoncurrent | 135,138,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 2,038,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 106,841,000 |
| 9 | ResearchAndDevelopmentExpense | 9,746,000 |
| 10 | remainder_Expenses | 13,239,000 |
| 11 | remainder_Revenues | 74,461,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -16,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 120,029,000 |
| 1 | Liabilities | 170,005,000 |
| 2 | Expenses | 131,864,000 |
| 3 | Revenues | 74,461,000 |
| 4 | StockholdersEquity | -49,976,000 |
| 5 | NetIncome | -57,403,000 |
| 6 | ComprehensiveNetIncome | -57,411,000 |
| 7 | BaseVar | 248,187,500 |
| 8 | EconomicCapitalRatio | -0.989 |
Edgar->Model Mapping
Feature Distribution
Change over Time
